Monday - March 16, 2026

Category Archives: Professional Services

E2 Visa Team Highlights EB-1A Extraordinary Ability and EB-2 National Interest Waiver Green Card Pathways for Highly Skilled Global Professionals

Employment-based self-petition immigration specialists report rising demand for EB-1A Extraordinary Ability and EB-2 National Interest Waiver green card pathways among physicians, engineers, researchers, entrepreneurs, and technology leaders. LOS ANGELES, California – E2 Visa Team, an internationally recognized employment-based self-petition immigration … Continue reading →

Gredi Nikollaj – DSN – DeepSeekNation.com – DeepSeek Sylt GmbH: The Five Strategic Pillars of Europe’s First AI Social Network

KAMPEN/SYLT – From Visionary to Pioneer: Gredi Nikollaj, founder of DeepSeek Sylt GmbH, has unveiled the five strategic pillars of his revolutionary platform DeepSeekNation.com – positioning it as “Germany’s Answer to Facebook” and the world’s first true AI Social Network. … Continue reading →

Sapropterin (KUVAN) Comprehensive Forecast on the Accelerating Market Growth for Phenylketonuria (PKU) and BH4 Deficiency by 2034

Sapropterin Sales Forecast, and Market Size Analysis – 2034 DelveInsight Releases In-Depth Drug Insight and Market Forecast Report on Sapropterin (developed and marketed by BioMarin Pharmaceutical Inc.) Sales Analysis Across the 7 Major Markets Through 2034 DelveInsight, a leading healthcare-focused … Continue reading →

Presbyopia Pipeline Insight Expands as 10+ Pharma Companies Progress Novel Therapies Toward Market Entry, Finds DelveInsight | Glaukos Corporation, Orasis Pharmaceuticals, Novartis, Cellix Bio

Presbyopia – Pipeline Insight, 2026 DelveInsight’s “Presbyopia – Pipeline Insight, 2026” report provides comprehensive insights about several companies, including Glaukos Corporation, Orasis Pharmaceuticals, Novartis, Cellix Bio, Visus Therapeutics, AbbVie, Vyluma, Lenz Therapeutics, Ocuphire Pharma, JIXING Pharmaceuticals, Eyenovia, and others, developing … Continue reading →